Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks

(1) Background: With the rise of multi-/pan-drug resistant (MDR/PDR) pathogens, the less utilized antibiotic Colistin has made a comeback. Colistin fell out of favor due to its small therapeutic range and high potential for toxicity. Today, it is used again as a last resort substance in treating MDR...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Stefan Felix Ehrentraut, Stefan Muenster, Stefan Kreyer, Nils Ulrich Theuerkauf, Christian Bode, Folkert Steinhagen, Heidi Ehrentraut, Jens-Christian Schewe, Matthias Weber, Christian Putensen, Thomas Muders
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2020-03-01
Serie:	Microorganisms
Soggetti:	colistin sepsis colistin methanosulfate therapeutic drug monitoring intensive care medicine renal failure polymyxin e acinetobacter baumannii carbapenem resistant
Accesso online:	https://www.mdpi.com/2076-2607/8/3/415
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!